Synthetic compounds from an in house library as inhibitors of falcipain-2 from Plasmodium falciparum

References

• WHO, World Malaria Report [Online]. 2013. Available from: http://www.who.int/malaria/publications/world_malaria_report_2013/wmr2013_no_profiles.pdf?ua=1 [last accessed 18 Feb 2014]
   Google Scholar
• Olliaro PL, Yuthavong Y. An Overview of chemotherapeutic targets for antimalarial drug discovery. Pharmacol Ther 1999;81:91–110
   PubMed Web of Science ®Google Scholar
• Shenai BR, Sijwali PS, Singh A, Rosenthal PJ. Characterization of native and recombinant falcipain-2, a principal trophozoite cysteine protease and essential hemoglobinase of Plasmodium falciparum. J Biol Chem 2000;275:29000–10
   PubMedGoogle Scholar
• Shenai BR, Rosenthal PJ. Reducing requirements for hemoglobin hydrolysis by Plasmodium falciparum cysteine proteases. Mol Biochem Parasitol 2002;122:99–104
   Google Scholar
• Sijwali PS, Rosenthal PJ. Gene disruption confirms a critical role for the cysteine protease falcipain-2 in hemoglobin hydrolysis by Plasmodium falciparum. Proc Natl Acad Sci USA 2004;101:4384–9
   PubMed Web of Science ®Google Scholar
• Sijwali PS, Shenai BR, Gut J, et al. Expression and characterization of the Plasmodium falciparum haemoglobinase falcipain-3. Biochem J 2001;360:481–9
   PubMedGoogle Scholar
• Marques AA, Esser D, Rosenthal PJ, et al. Falcipain-2 inhibition by suramin and suramin analogues. Biorg Med Chem 2013;21:3667–73
   Google Scholar
• Pérez B, Gomes JRB, Gomes P. Development of Plasmodium falciparum protease inhibitors in the past decade (2002–2012). Curr Med Chem 2013;20:3049–68
   Google Scholar
• Ettari R, Bova F, Zappalà M, et al. Falcipain-2 inhibitors. Med Res Rev 2010;30:136–67
   Google Scholar
• Shenai BR, Lee BJ, Alvarez-Hernandez A, et al. Structure-activity relationships for inhibition of cysteine protease activity and development of Plasmodium falciparum by peptidyl vinyl sulfones. Antimicrob Agents Chemother 2003;47:154–60
   PubMed Web of Science ®Google Scholar
• Coterón JM, Catterick D, Castro J, et al. Falcipain inhibitors: optimization studies of the 2-pyrimidinecarbonitrile lead series. J Med Chem 2010;53:6129–52
   PubMed Web of Science ®Google Scholar
• Dewick PM. Medicinal natural products: a biosinthetic approach. Cichestes: John Wiley & Sons; 1997:136–7
   Google Scholar
• Ow YY, Stupans I. Gallic acid and gallic acid derivatives: effects on drug metabolizing enzymes. Curr Drug Metab 2003;4:241–8
   PubMed Web of Science ®Google Scholar
• Nowakowska ZA. A review of anti-infective and anti-inflammatory chalcones. Eur J Med Chem 2007;42:125–37
   PubMed Web of Science ®Google Scholar
• Ni L, Meng CQ, Sikorski JA. Recent advances in therapeutic chalcones. Expert Opin Ther Pat 2004;14:1669–91
   Web of Science ®Google Scholar
• Rollas S, Küçükgüzel SG. Biological activities of hydrazone derivatives. Molecules 2007;12:1910–39
   PubMed Web of Science ®Google Scholar
• Locatelli C, Filippin-Monteiro FB, Creczynski-Pasa TB. Alkyl esters of gallic acid as anticancer agents: a review. Eur J Med Chem 2013;60:233–9
   PubMed Web of Science ®Google Scholar
• Kubo I, Xiao P, Fujita K. Anti-MRSA activity of alkyl gallates. Bioorg Med Chem Lett 2002;12:113–16
   PubMed Web of Science ®Google Scholar
• Savi LA, Leal PC, Vieira TO, et al. Evaluation of anti-herpetic and antioxidant activities, and cytotoxic and genotoxic effects of synthetic alkyl-esters of gallic acid. Arzneimittelforschung 2005;55:66–75
   PubMed Web of Science ®Google Scholar
• Borchhardt DM, Mascarello A, Chiaradia LD, et al. Biochemical evaluation of a series of synthetic chalcone and hydrazide derivatives as novel inhibitors of cruzain from Trypanosoma cruzi. J Braz Chem Soc 2010;21:142–50
   Web of Science ®Google Scholar
• Chiaradia LD, Mascarello A, Purificação M, et al. Synthetic chalcones as efficient inhibitors of Mycobacterium tuberculosis protein tyrosine phosphatase PtpA. Biorg Med Chem Lett 2008;18:6227–30
   PubMed Web of Science ®Google Scholar
• Bello ML, Chiaradia LD, Dias LRS, et al. Trimethoxy-chalcone derivatives inhibit growth of Leishmania braziliensis: synthesis, biological evaluation, molecular modeling and structure–activity relationship (SAR). Biorg Med Chem 2011;19:5046–52
   PubMed Web of Science ®Google Scholar
• Chiaradia LD, Martins PGA, Cordeiro MNS, et al. Synthesis, biological evaluation, and molecular modeling of chalcone derivatives as potent inhibitors of Mycobacterium tuberculosis protein tyrosine phosphatases (PtpA and PtpB). J Med Chem 2012;55:390–402
   PubMedGoogle Scholar
• Salum LB, Altei WF, Chiaradia LD, et al. Cytotoxic 3,4,5-trimethoxychalcones as mitotic arresters and cell migration inhibitors. Eur J Med Chem 2013;63:501–10
   PubMed Web of Science ®Google Scholar
• Osório TM, Delle Monache F, Chiaradia LD, et al. Antibacterial activity of chalcones, hydrazones and oxadiazoles against methicillin-resistant Staphylococcus aureus. Bioorg Med Chem Lett 2012;22:225–30
   Google Scholar
• Mascarello A, Nunes RJ, Yunes RA, et al. Compostos acil-hidrazonas e oxadiazóis, composições farmacêuticas compreendendo os mesmos e seus usos, Patent WO 2013/075199 A1; 2013
   Google Scholar
• Nunes AS, Campos VP, Mascarello A, et al. Activity of chalcones derived from 2,4,5-trimethoxybenzaldehyde against Meloidogyne exigua and in silico interaction of one chalcone with a putative caffeic acid 3-O-methyltransferase from Meloidogyne incognita. Exp Parasitology 2013;135:661–8
   PubMed Web of Science ®Google Scholar
• Ferreira NC, Marques IA, Conceição WA, et al. Anti-prion activity of a panel of aromatic chemical compounds: in vitro and in silico approaches. PLoS One 2014;9:e84531
   PubMed Web of Science ®Google Scholar
• Stumpf TR. Síntese de 2,4,5-trimetoxichalconas e avaliação de sua Atividade frente à proteína tirosina fosfatase a (PtpA) de Mycobacterium tuberculosis. Available from: https://repositorio.ufsc.br/xmlui/handle/123456789/96776 [last accessed 18 Feb 2014]
   Google Scholar
• Sarduy ES, Muñoz AC, Trejo SA, Chavéz Planes MDLA. High-level expression of falcipain-2 in Escherichia coli by codon optimization and auto-induction. Protein Expr Purif 2012;83:59–69
   Google Scholar
• Sijwali PS, Brinen LS, Rosenthal PJ. Systematic optimization of expression and refolding of the Plasmodium falciparum cysteine protease falcipain-2. Protein Expr Purif 2001;22:128–34
   Google Scholar
• Mascarello A, Mori M, Chiaradia-Delatorre LD, et al. Discovery of Mycobacterium tuberculosis protein tyrosine phosphatase B (PtpB) inhibitors from natural products. PLoS One 2013;8:e77081
   PubMed Web of Science ®Google Scholar
• Hogg T, Nagarajan K, Herzberg S, et al. Structural and functional characterization of falcipain-2, a hemoglobinase from the malarial Parasite Plasmodium falciparum. J Biol Chem 2006;281:25425–37
   PubMed Web of Science ®Google Scholar